Cargando…

Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action

Direct and indirect costs of care influence patients’ health choices and the ability to implement those choices. Despite the significant impact of care costs on patients’ health and daily lives, patient decision aid (PtDA) and shared decision-making (SDM) guidelines almost never mention a discussion...

Descripción completa

Detalles Bibliográficos
Autores principales: Politi, Mary C., Housten, Ashley J., Forcino, Rachel C., Jansen, Jesse, Elwyn, Glyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834940/
https://www.ncbi.nlm.nih.gov/pubmed/36643615
http://dx.doi.org/10.1177/23814683221148651
_version_ 1784868572670984192
author Politi, Mary C.
Housten, Ashley J.
Forcino, Rachel C.
Jansen, Jesse
Elwyn, Glyn
author_facet Politi, Mary C.
Housten, Ashley J.
Forcino, Rachel C.
Jansen, Jesse
Elwyn, Glyn
author_sort Politi, Mary C.
collection PubMed
description Direct and indirect costs of care influence patients’ health choices and the ability to implement those choices. Despite the significant impact of care costs on patients’ health and daily lives, patient decision aid (PtDA) and shared decision-making (SDM) guidelines almost never mention a discussion of costs of treatment options as part of minimum standards or quality criteria. Given the growing study of the impact of costs in health decisions and the rising costs of care more broadly, in fall 2021 we organized a symposium at the Society for Medical Decision Making’s annual meeting. The focus was on the role of cost information in PtDAs and SDM. Panelists gave an overview of work in this space at this virtual meeting, and attendees engaged in rich discussion with the panelists about the state of the problem as well as ideas and challenges in incorporating cost-related issues into routine care. This article summarizes and extends our discussion based on the literature in this area and calls for action. We recommend that PtDA and SDM guidelines routinely include a discussion of direct and indirect care costs and that researchers measure the frequency, quality, and response to this information.
format Online
Article
Text
id pubmed-9834940
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-98349402023-01-13 Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action Politi, Mary C. Housten, Ashley J. Forcino, Rachel C. Jansen, Jesse Elwyn, Glyn MDM Policy Pract Review Direct and indirect costs of care influence patients’ health choices and the ability to implement those choices. Despite the significant impact of care costs on patients’ health and daily lives, patient decision aid (PtDA) and shared decision-making (SDM) guidelines almost never mention a discussion of costs of treatment options as part of minimum standards or quality criteria. Given the growing study of the impact of costs in health decisions and the rising costs of care more broadly, in fall 2021 we organized a symposium at the Society for Medical Decision Making’s annual meeting. The focus was on the role of cost information in PtDAs and SDM. Panelists gave an overview of work in this space at this virtual meeting, and attendees engaged in rich discussion with the panelists about the state of the problem as well as ideas and challenges in incorporating cost-related issues into routine care. This article summarizes and extends our discussion based on the literature in this area and calls for action. We recommend that PtDA and SDM guidelines routinely include a discussion of direct and indirect care costs and that researchers measure the frequency, quality, and response to this information. SAGE Publications 2023-01-10 /pmc/articles/PMC9834940/ /pubmed/36643615 http://dx.doi.org/10.1177/23814683221148651 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Politi, Mary C.
Housten, Ashley J.
Forcino, Rachel C.
Jansen, Jesse
Elwyn, Glyn
Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action
title Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action
title_full Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action
title_fullStr Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action
title_full_unstemmed Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action
title_short Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action
title_sort discussing cost and value in patient decision aids and shared decision making: a call to action
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834940/
https://www.ncbi.nlm.nih.gov/pubmed/36643615
http://dx.doi.org/10.1177/23814683221148651
work_keys_str_mv AT politimaryc discussingcostandvalueinpatientdecisionaidsandshareddecisionmakingacalltoaction
AT houstenashleyj discussingcostandvalueinpatientdecisionaidsandshareddecisionmakingacalltoaction
AT forcinorachelc discussingcostandvalueinpatientdecisionaidsandshareddecisionmakingacalltoaction
AT jansenjesse discussingcostandvalueinpatientdecisionaidsandshareddecisionmakingacalltoaction
AT elwynglyn discussingcostandvalueinpatientdecisionaidsandshareddecisionmakingacalltoaction